Arg1201Gln mutation of insulin receptor impairs tyrosine kinase activity and causes insulin resistance: a case report

References

• Hubbard SR, Wei L, Hendrickson WA. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature. 1994;372(6508):746–754.
   PubMed Web of Science ®Google Scholar
• Moller DE, Flier JS. Insulin resistance–mechanisms, syndromes, and implications. N Engl J Med. 1991;325:938–948.
   PubMed Web of Science ®Google Scholar
• Flier JS, Young JB, Landsberg L. Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps. N Engl J Med. 1980;303(17):970–973.
   PubMed Web of Science ®Google Scholar
• Takasawa K, Tsuji-Hosokawa A, Takishima S, et al. Clinical characteristics of adolescent cases with Type A insulin resistance syndrome caused by heterozygous mutations in the beta-subunit of the insulin receptor (INSR) gene. J Diabetes. 2019;11(1):46–54.
   PubMed Web of Science ®Google Scholar
• Krook A, Moller DE, Dib K, et al. Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action. J Biol Chem. 1996;271(12):7134–7140.
   PubMed Web of Science ®Google Scholar
• Vestergaard H, Klein HH, Hansen T, et al. Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy. J Clin Invest. 1995;95(4):1925–1932.
   PubMed Web of Science ®Google Scholar
• Moller DE, Cohen O, Yamaguchi Y, et al. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 1994;43(2):247–255.
   PubMed Web of Science ®Google Scholar
• Højlund K, Hansen T, Lajer M, et al. A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes. 2004;53:1592–1598.
   PubMed Web of Science ®Google Scholar
• Rau H, Kocova M, O'Rahilly S, et al. Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes. 2000;49(7):1264–1268.
   PubMed Web of Science ®Google Scholar
• Klein HH, Muller R, Vestergaard H, et al. Implications of compound heterozygous insulin receptor mutations in congenital muscle fibre type disproportion myopathy for the receptor kinase activation. Diabetologia. 1999;42(2):245–249.
   PubMed Web of Science ®Google Scholar
• Moritz W, Froesch ER, Boni-Schnetzler M. Functional properties of a heterozygous mutation (Arg1174–>Gln) in the tyrosine kinase domain of the insulin receptor from a type A insulin resistant patient. FEBS Lett. 1994;351(2):276–280.
   PubMed Web of Science ®Google Scholar
• Cocozza S, Porcellini A, Riccardi G, et al. NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes. 1992;41(4):521–526.
   PubMed Web of Science ®Google Scholar
• Lee J, Pilch PF. The insulin receptor: structure, function, and signaling. Am J Physiol. 1994;266(2):C319–334.
   PubMedGoogle Scholar
• Kido Y, Nakae J, Accili D. Clinical review 125: The insulin receptor and its cellular targets. J Clin Endocrinol Metab. 2001;86:972–979.
   PubMed Web of Science ®Google Scholar
• Taylor SI. Lilly lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 1992;41(11):1473–1490.
   PubMed Web of Science ®Google Scholar
• Bremer AA, Miller WL. The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril. 2008;89(5):1039–1048.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Maitra A. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res. 2010;131:743–760.
   PubMed Web of Science ®Google Scholar
• Vuguin PM. Interventional studies for polycystic ovarian syndrome in children and adolescents. Ped Health. 2010;4(1):59–73.
   PubMedGoogle Scholar
• Poretsky L, Cataldo NA, Rosenwaks Z, et al. The insulin-related ovarian regulatory system in health and disease. Endocr Rev. 1999;20(4):535–582.
   PubMed Web of Science ®Google Scholar
• Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5:199–203.
   PubMed Web of Science ®Google Scholar
• Semple RK, Savage DB, Cochran EK, et al. Genetic syndromes of severe insulin resistance. Endocr Rev. 2011;32(4):498–514.
   PubMed Web of Science ®Google Scholar
• Huang Z, Li Y, Tang T, et al. Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) gene. Clin Endocrinol (Oxf). 2009;71(5):659–665.
   PubMed Web of Science ®Google Scholar
• Preumont V, Feincoeur C, Lascols O, et al. Hypoglycaemia revealing heterozygous insulin receptor mutations. Diabetes Metab. 2017;43(1):95–96.
   PubMed Web of Science ®Google Scholar
• Accili D, Frapier C, Mosthaf L, et al. A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes. Embo J. 1989;8(9):2509–2517.
   PubMed Web of Science ®Google Scholar
• Ogawa W, Iwamoto K, Mori H, et al. Two related cases of type A insulin resistance with compound heterozygous mutations of the insulin receptor gene. Diabetes Res Clin Pract. 2009;83(3):e75–77.
   PubMedGoogle Scholar
• Melvin A, O’Rahilly S, Savage DB. Genetic syndromes of severe insulin resistance. Curr Opin Genet Dev. 2018;50:60–67.
   PubMed Web of Science ®Google Scholar
• Young J, Morbois-Trabut L, Couzinet B, et al. Type A insulin resistance syndrome revealing a novel lamin A mutation. Diabetes. 2005;54(6):1873–1878.
   PubMed Web of Science ®Google Scholar